INTRODUCTION
Atopic dermatitis (AD) is a chronic, highly pruritic, inflammatory skin disease that manifests as eczematous skin lesions [1] [2] [3] . A skin lesion in AD is characterized by preferential infiltration of activated T cells, monocytes/macrophages, and eosinophils.
Although it has been proposed that T helper (Th) 2-type cells play a key role in the pathogenesis of AD 6, 9, 10 . Furthermore, chronic activation of macrophages/monocytes with increased cytokine secretion is the other immune dysfunction that characterizes AD 11 .
The development of cutaneous lesions in AD is closely related to the accumulation of these leukocytes migrating from the blood into the affected skin through the endothelium. This process is highly dependent on expression of chemokines and chemokine receptors as well as adhesion molecules 7 .
Fractalkine (FKN) or CX 3 CL1 is a CX 3 C chemokine that is expressed on activated vascular endothelial cells stimulated with IL-1, tumor necrosis factor-α, or IFN-γ 12, 13 . FKN is expressed in various organs including skin, tonsils, brain, and kidney 12, [14] [15] [16] and interacts with its unique receptor, CX 3 CR1, expressed on monocytes, natural killer (NK) cells, and some T cells. FKN and CX 3 CR1 represent a novel type of leukocyte trafficking molecule that regulates both adhesive and chemotactic functions 17 . The membrane-bound FKN is able to mediate firm adhesion of CX 3 CR1-expressing leukocytes without requiring selectin-mediated rolling or activation of integrins 18, 19 . , were also examined by ELISA.
Flow cytometric analysis
CX 3 CR1 expression levels by peripheral blood leukocytes were examined in patients with AD (n=16, 10 severe and 6 moderate AD patients, 7 females and 9 males, 25.5 ± 5.8 years old), those with psoriasis (n=8, 4 females and 4 males, 33.2 ± 7.8 years old), and normal controls (n=10, 4 females and 6 males, 28.3 ± 6.2 years old). 
RNA isolation and real-time reverse transcription (RT)-polymerase chain reaction (PCR)
Total RNA was isolated from frozen tissue of 5 chronic skin lesions of AD patients (3 females and 2 males, 27.4 ± 4.6 years old), and 5 normal controls ( expression, relative expression of real-time PCR products was determined using the ΔΔCt method 25 . One of the control samples was chosen as a calibrator sample.
Statistical Analysis
The Mann-Whitney U tests were used to compare variables between 2 groups and Bonferroni's test was used for multiple comparisons. Spearman's rank correlation coefficient was used to examine the relationship between two continuous variables. A p value <0.05 was considered statistically significant. All data are shown as mean ± SD.
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RESULTS
Expression of FKN and CX 3 CR1 in the skin
We performed immunohistochemical analysis using specific Ab to assess FKN expression in the affected skin from patients with AD. In the skin from normal individuals, FKN was not expressed on endothelial cells. In contrast, vascular endothelial cells strongly expressed FKN in the affected skin, but not in the unaffected skin of patients with AD or psoriasis (Fig. 1A and data not shown) . Then, we examined the distribution of CX 
Serum sFKN levels
Since FKN is released from the cell surface as a soluble form 12 , sFKN levels
were assessed in serum samples from AD patients (Fig. 2) . Serum sFKN levels in patients with AD were significantly 5.1-fold higher than those in normal controls (81 ± 153 vs. 16 ± 11 pg/ml, p<0.05). By contrast, patients with psoriasis (34 ± 51 pg/ml) or contact dermatitis (22 ± 20 pg/ml) showed mean sFKN levels similar to those of normal controls. The affected skin area was similar in AD patients (52 ± 23% of total body) and psoriasis patients (49 ± 26%), suggesting that sFKN levels were not simply determined by the extent of skin disease. Regarding the severity of AD, severe AD patients (141 ± 201 pg/ml) exhibited significantly increased sFKN levels compared with moderate AD patients (21 ± 15 pg/ml, p<0.05). Furthermore, sFKN levels were significantly elevated in severe AD patients relative to patients with psoriasis (p<0.05) or contact dermatitis (p<0.05) as well as normal controls (p<0.005). However, sFKN levels in moderate AD patients were comparable with those in normal controls. Blood eosinophil numbers and serum IgE levels did not correlate with the serum sFKN levels in AD patients (data not shown). We determined correlation of sFKN levels with serum levels of TARC and MDC that are increased in sera form AD patients 27, 28 . Serum sFKN levels correlated positively with serum levels of TARC (r=0.757, p<0.0001) or MDC (r=0.370, p<0.05). Thus, serum sFKN levels were elevated in patients with AD, especially severe AD, but not in other skin disorders, including psoriasis and contact dermatitis.
To determine the treatment effect on sFKN levels, 23 patients with severe AD were examined for serum sFKN levels before and after treatment. The skin lesions in all patients significantly improved (the score changed from 7.6 ± 1.2 to 4. Patients with AD exhibited elevated sFKN levels that significantly decreased with the improvement of skin lesions by treatment. Since sFKN enhances the chemotactic activity of CX 3 CR1-expressing cells 12, 43, 44 , sFKN may promote CX 3 CR1 + cell infiltration into the affected tissue. However, recent studies have revealed that sFKN inhibits the adhesion of CX 3 CR1-expressing leukocytes to endothelial cells 12, 29, 43, 44 . A similar function has been reported in other adhesion molecules including L-selectin 45, 46 . Circulating L-selectin likely serves as a biologic buffer system to prevent leukocyte rolling at sites of subacute inflammation 45, 47 . In a similar way, the increase in sFKN may reflect the defence system to avoid excessive inflammatory cell infiltration by inhibiting the adhesion of CX 3 CR1 + leukocytes to endothelial cells in AD.
Thus, although the biological significance of sFKN remains unclear, sFKN may be related to the inflammation associated with AD by interfering with cell to cell interaction. However, we cannot exclude the possibility that FKN is related to the development of general skin inflammation, since local FKN expression was not significantly different between AD and psoriasis. Further studies will be needed to determine the relative importance of FKN in AD compared to other skin inflammatory diseases.
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